2nd Circ. Novartis Ruling Muddies Sales Rep OT Issue

By Elaine Meyer (July 9, 2010, 5:58 PM EDT) -- The U.S. Court of Appeals for the Second Circuit's July 6 decision finding that drug industry representatives at Novartis Pharmaceuticals Corp. were not exempt from the nation's overtime laws muddies the legal landscape and leaves the contentious issue ripe for a definitive ruling, employment lawyers say.

Although the Second Circuit opinion — which found that drug representatives should not be subject to either the outside sales or administrative exemptions of the Fair Labor Standards Act — is the most decisive appeals court ruling to date, it differs from many district courts, and the U.S. Court of Appeals for the Third Circuit,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!